The White House has sounded the alarm about vulnerabilities in the pharmaceutical supply chain. But new research from the Center for Analytics and Business Insights at Olin Business School found that the U.S. actually has the capacity to make the nation’s most essential and critical drugs — yet it’s mostly sitting idle.
Panos Kouvelis, at Olin Business School, is the 2022 recipient of the Manufacturing and Service Operations Management Society’s Distinguished Fellow Award, widely regarded as the highest honor that can be bestowed upon a research scholar in the field of operations management.
New Olin Business School research suggests strategies for how nonprofits can handle the issue of costly, unwanted donations while minimizing the risk of donor backlash.
Josiah Cox’s utilities company has grown to service multiple states while also changing how we access clean water.
Panos Kouvelis, director of The Boeing Center for Supply Chain Innovation, said, optimistically, supply chains could recover by next summer. But if the energy crisis in China doesn’t resolve quickly, “2022 will be driven by that crisis and the constraints that it creates.”
Research provides blueprint for development of sustainable milk production supply chain, where milk waste is reduced in a way that is cost-effective, socially acceptable and environmentally sound.
In a business famed for slow and patient aging, it’s been a meteoric rise. Just six years ago, former WashU roommates David Mandell and Daniel Linde stood on a rolling cornfield at the eastern edge of Bardstown, Kentucky. Today, the 100-acre site is home to their Bardstown Bourbon Company, already one of the world’s largest bourbon distilleries.
Panos Kouvelis, director of The Boeing Center for Supply Chain Innovation and the Emerson Distinguished Professor of Operations and Manufacturing Management at Olin Business School at Washington University in St. Louis, has been appointed editor-in-chief of Foundations and Trends in Technology, Information and Operations Management.
Resilience, once a hallmark that academics ascribed to the most successful supply chains, has become a “matter of survival,” writes an international team of researchers including an Olin Business School expert from Washington University in St. Louis.
The cold, hard fact is: Pfizer blazed a trail in creating a touted COVID-19 vaccine, but now it must help to equally pioneer an unprecedented way to distribute the drug across the United States and the globe, says a supply chain expert at Washington University in St. Louis.